Discussion forum.
Queries from European physicians about analgesic pharmacotherapy and responses from the author are presented. The topics addressed are the safety of propoxyphene, the risk of opioid dependence in nonmalignant pain, the role of ziconotide in pain management, and titration of sustained acting opioids.
Eisenberg
Elon
E
Pain Relief Unit, Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, 31096, Israel. e_eisenberg@rambam.health.gov.il
D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009293:Opioid-Related Disorders; D010146:Pain / Q000188:drug therapy*; D020960:omega-Conotoxins / Q000008:administration & dosage / Q000627:therapeutic use*
D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D020960:omega-Conotoxins; C078452:ziconotide; D011431:Dextropropoxyphene